Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emadoldin Feyzi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biomacromolecules|September 26, 2015
The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2Øystein Arlov, Finn L Aachmann, Emadoldin Feyzi, et al.
Plos One|October 8, 2015
PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 TherapyAnne-Marit Sponaas, Neda Nejati Moharrami, Emadoldin Feyzi, et al.
Current Pharmaceutical Biotechnology|February 22, 2008
RNA base damage and repairEmadoldin Feyzi, Ottar Sundheim, Marianne Pedersen Westbye, et al.
DNA Repair|September 24, 2004
Alkylation damage in DNA and RNA--repair mechanisms and medical significanceFinn Drabløs, Emadoldin Feyzi, Per Arne Aas, et al.
Immunity, Inflammation and Disease|June 2, 2015
The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myelomaAnne M Sponaas, Siv H Moen, Nina B Liabakk, et al.
The Journal of Biological Chemistry|July 8, 2008
Human AlkB homolog 1 is a mitochondrial protein that demethylates 3-methylcytosine in DNA and RNAMarianne Pedersen Westbye, Emadoldin Feyzi, Per Arne Aas, et al.
The Journal of Cell Biology|September 9, 2009
Identification of a novel, widespread, and functionally important PCNA-binding motifKarin M Gilljam, Emadoldin Feyzi, Per A Aas, et al.
The New England Journal of Medicine|December 8, 2025
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic LeukemiaOthman Al-Sawaf, Janina Stumpf, Can Zhang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biomacromolecules|September 26, 2015
The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2Øystein Arlov, Finn L Aachmann, Emadoldin Feyzi, et al.
Plos One|October 8, 2015
PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 TherapyAnne-Marit Sponaas, Neda Nejati Moharrami, Emadoldin Feyzi, et al.
Current Pharmaceutical Biotechnology|February 22, 2008
RNA base damage and repairEmadoldin Feyzi, Ottar Sundheim, Marianne Pedersen Westbye, et al.
DNA Repair|September 24, 2004
Alkylation damage in DNA and RNA--repair mechanisms and medical significanceFinn Drabløs, Emadoldin Feyzi, Per Arne Aas, et al.
Immunity, Inflammation and Disease|June 2, 2015
The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myelomaAnne M Sponaas, Siv H Moen, Nina B Liabakk, et al.
The Journal of Biological Chemistry|July 8, 2008
Human AlkB homolog 1 is a mitochondrial protein that demethylates 3-methylcytosine in DNA and RNAMarianne Pedersen Westbye, Emadoldin Feyzi, Per Arne Aas, et al.
The Journal of Cell Biology|September 9, 2009
Identification of a novel, widespread, and functionally important PCNA-binding motifKarin M Gilljam, Emadoldin Feyzi, Per A Aas, et al.
The New England Journal of Medicine|December 8, 2025
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic LeukemiaOthman Al-Sawaf, Janina Stumpf, Can Zhang, et al.
Pageof 1